140 related articles for article (PubMed ID: 30851261)
21. Providing clinicians with a patient's 10-year cardiovascular risk improves their statin prescribing: a true experiment using clinical vignettes.
Sekaran NK; Sussman JB; Xu A; Hayward RA
BMC Cardiovasc Disord; 2013 Oct; 13():90. PubMed ID: 24148829
[TBL] [Abstract][Full Text] [Related]
22. Cholesterol drug lowers LDL-C levels but again fails to show clinical benefit.
Mitka M
JAMA; 2010 Jan; 303(3):211-2. PubMed ID: 20085945
[No Abstract] [Full Text] [Related]
23. Audit-based education to reduce suboptimal management of cholesterol in primary care: a before and after study.
de Lusignan S; Belsey J; Hague N; Dhoul N; van Vlymen J
J Public Health (Oxf); 2006 Dec; 28(4):361-9. PubMed ID: 17038329
[TBL] [Abstract][Full Text] [Related]
24. Statin prescribing according to gender, age and indication: what about the benefit-risk balance?
Wallach-Kildemoes H; Stovring H; Holme Hansen E; Howse K; Pétursson H
J Eval Clin Pract; 2016 Apr; 22(2):235-46. PubMed ID: 26446680
[TBL] [Abstract][Full Text] [Related]
25. Statin Prescribing Practices in the Comprehensive Care for HIV-Infected Patients.
Kelly SG; Krueger KM; Grant JL; Penugonda S; Feinstein MJ; Taiwo BO; Achenbach CJ
J Acquir Immune Defic Syndr; 2017 Sep; 76(1):e26-e29. PubMed ID: 28520617
[No Abstract] [Full Text] [Related]
26. Key factors influencing the prescribing of statins: a qualitative study among physicians working in primary healthcare facilities in Indonesia.
Irawati S; Prayudeni S; Rachmawati R; Wita IW; Willfert B; Hak E; Taxis K
BMJ Open; 2020 Jun; 10(6):e035098. PubMed ID: 32540888
[TBL] [Abstract][Full Text] [Related]
27. Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk.
Schilling C; Knight J; Mortimer D; Petrie D; Clarke P; Chalmers J; Kerr A; Jackson R
Health Policy; 2017 Dec; 121(12):1233-1239. PubMed ID: 29042060
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular risk perception and evidence--practice gaps in Australian general practice (the AusHEART study).
Heeley EL; Peiris DP; Patel AA; Cass A; Weekes A; Morgan C; Anderson CS; Chalmers JP
Med J Aust; 2010 Mar; 192(5):254-9. PubMed ID: 20201758
[TBL] [Abstract][Full Text] [Related]
29. A cluster randomised controlled trial of pharmacist led statin outreach support (SOS) in primary care: design and baseline characteristics.
Lowrie R; Morrison J; McConnachie A
Contemp Clin Trials; 2010 Jul; 31(4):303-11. PubMed ID: 20348032
[TBL] [Abstract][Full Text] [Related]
30. Use of statins and aspirin to reduce risks of cardiovascular disease.
Hebert PR; Pfeffer MA; Hennekens CH
J Cardiovasc Pharmacol Ther; 2002 Apr; 7(2):77-80. PubMed ID: 12075395
[No Abstract] [Full Text] [Related]
31. Statins for secondary cardiovascular disease prevention for older primary care patients.
Niska R; Han B
J Natl Med Assoc; 2009 Jul; 101(7):705-10. PubMed ID: 19634592
[TBL] [Abstract][Full Text] [Related]
32. Use of cardiovascular medicines in newly treated type 2 diabetes patients: A retrospective cohort study in general practice.
Grimes RT; Ensor J; Bennett K; Henman MC
Prim Care Diabetes; 2016 Aug; 10(4):237-43. PubMed ID: 26654852
[TBL] [Abstract][Full Text] [Related]
33. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
[TBL] [Abstract][Full Text] [Related]
34. Medication-based versus target-based lipid management.
Fazio S; Shapiro MD
J Diabetes; 2018 Oct; 10(10):789-792. PubMed ID: 29962061
[No Abstract] [Full Text] [Related]
35. Regarding "Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study".
Goldstein MR; Mascitelli L; Pezzetta F
J Vasc Surg; 2009 Jun; 49(6):1632-3; author reply 1633. PubMed ID: 19497532
[No Abstract] [Full Text] [Related]
36. Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish national health service: influence and implications.
Leporowski A; Godman B; Kurdi A; MacBride-Stewart S; Ryan M; Hurding S; Do Nascimento RC; Bennie M; Morton A
Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):655-666. PubMed ID: 30014725
[TBL] [Abstract][Full Text] [Related]
37. Effect of simvastatin-amiodarone drug interaction alert on appropriate prescribing.
Prom R; Umscheid CA; Kasbekar N; Spinler SA
Am J Health Syst Pharm; 2013 Nov; 70(21):1878-9. PubMed ID: 24128959
[No Abstract] [Full Text] [Related]
38. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
[TBL] [Abstract][Full Text] [Related]
39. Discussion.
J Vasc Surg; 2015 Apr; 61(4):1019. PubMed ID: 25601507
[No Abstract] [Full Text] [Related]
40. [Current knowledge about the effect of HMG-CoA reductase inhibitors].
Gesche M
Dtsch Med Wochenschr; 1998 Jan; 123(5):135. PubMed ID: 9487300
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
